{
  "report_rows": [
    {
      "kpi": "Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$3.04B vs. cons $3.018B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Non-GAAP EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.54 vs. cons $1.51",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "GMV",
      "prediction": "BEAT",
      "answer": "pred ~$21.80B vs. cons $21.55B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Q3 revenue",
      "prediction": "BETTER",
      "answer": "guide ~$3.03B vs. cons $3.01B (Q3 2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3 non-GAAP EPS",
      "prediction": "LOWER",
      "answer": "guide ~$1.53 vs. cons $1.55 (Q3 2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 FX-neutral GMV growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~7.25% vs. cons 7.25% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 non-GAAP operating-income growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~10.0% vs. cons 10.0% (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 3.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 1.0,
  "day5_path": "FADE",
  "day5_rationale": "A modest ~$0.03 EPS beat and ~$0.25B GMV beat should initially support a ~3.5% residual move, but Q3 EPS guide of ~$1.53 versus ~$1.55 consensus implies reinvestment and tougher comparison effects; unchanged ~7.25% FY GMV and ~10.0% operating-income growth leave limited out-period estimate-upside support.",
  "day5_confidence": "MEDIUM"
}